GU Cancers 2019 | Dr Caffo’s highlights from the 2019 GU Cancers symposium
Orazio Caffo
• 14 Feb 2019
Orazio Caffo, MD, of the Santa Chiara Hospital, Trento, Italy, speaks at the 2019 Genitourinary Cancers Symposium, held in San Francisco, CA, sharing his thoughts on the most exciting trial and data updates we can expect to see in the prostate cancer arena.
Transcript (edited for clarity)
In this moment, I think the major information will be about data concerning enzalutamide in the early setting of patients or ARN-509 in this setting of patients.
In this moment, I think the major information will be about data concerning enzalutamide in the early setting of patients or ARN-509 in this setting of patients.
Read more...
